AMGN34:BVMF
Amgen Inc. BDR
R$ ८१.०४
०.००%
(०.००) 1D
अक्टोबर २२, १६:५६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$ ७९.००
High
R$ ८१.०४
Low
R$ ७९.००
Mkt. cap
२.४२ खरब
Avg. vol.
४२५.००
Volume
७१२.००
52-wk high
R$ ८३.०६
52-wk low
R$ ४७.७६
Shares outstanding
५४.०६ करोड
No. of employees
३२ हजार
Open
R$ ७९.००
High
R$ ८१.०४
Low
R$ ७९.००
Mkt. cap
२.४२ खरब
Avg. vol.
४२५.००
Volume
७१२.००
52-wk high
R$ ८३.०६
52-wk low
R$ ४७.७६
Shares outstanding
५४.०६ करोड
No. of employees
३२ हजार
News stories
From web sources and news partners
The Motley Fool
·
१० घण्टा पहिले
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Investor's Business Daily
·
१२ घण्टा पहिले
Tech Stocks Hit, Yields Plunge As AI Trade Fizzles: NetApp, Amgen, Nasdaq In Focus
Investing.com Nigeria
·
१८ घण्टा पहिले
Amgen stock hits all-time high at 447.09 USD By Investing.com
Yahoo Finance
·
१ दिन पहिले
Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees३१.५ हजार
Founded१९८०
Headquartersथाउजेन्ड ओक्स, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteamgen.com